Business · 1 sources covering this

Sun Pharma Faces Legal Setback Over Semaglutide Launch Amid Novo Nordisk Patent Suit

The judicial directive stems from a patent infringement suit filed by Danish drugmaker Novo Nordisk, which alleges that Sun Pharma's proposed generic tablets violate its existing patents.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
Sun Pharma Faces Legal Setback Over Semaglutide Launch Amid Novo Nordisk Patent Suit
The judicial directive stems from a patent infringement suit filed by Danish drugmaker Novo Nordisk, which alleges that Sun Pharma's proposed generic tablets violate its existing patents.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/b27e629fca3f228c18e507fc01870966037bdd8d"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sun Pharma Faces Legal Setback Over Semaglutide Launch Amid Novo Nordisk Patent Suit"></iframe>

Sun Pharma Faces Legal Setback Over Semaglutide Launch Amid Novo Nordisk Patent Suit

How 1 sources are covering this

Sun Pharma Faces Legal Setback Over Semaglutide Launch Amid Novo Nordisk Patent Suit

More from Business

Shivaji Maharaj Statue Targeted In Pune: Woman Allegedly Throws Slipper, Stones; Locals Confront Her

US Stock Market Today: Dow Rises As Wall Street Shrugs Off Oil Fears; Nasdaq In Red Despite Nvidia Surge

Mutual fund investors rejig portfolios, favour select debt funds over equities in July 2026

Mirzapur: The Movie Official Trailer Releases: Kaleen Bhaiya's Power-Packed Dialogue Steals The Show

Reader

Trust & legal

Across the network